Ennature Biopharma is the natural ingredients division of India Glycols, set up in 2009 to leverage the India Glycols expertise in advanced green technologies and to develop high quality, plant-based ingredients for the pharmaceutical and nutraceutical industries
India Glycols is a USD 750 million listed, global leader in specialty, bio-based, chemicals since 1984
India Glycols has been a pioneer of green technologies and holds the distinction of being the first and only company in the world to commercialize the production of ethylene oxide and glycols from renewable agricultural feedstocks

Who We Are

At Ennature Biopharma, we develop, and manufacture value-added, plant-based ingredients for pharmaceutical, nutraceutical, and food and beverage industries
We source our raw materials mainly from India, with strong partnerships, and farmer connect to ensure the sustainability and quality at the source
We use 100% green SCF- CO₂ technology to manufacture our nutraceutical actives and have an exceptionally strong manufacturing and green technology base
We hold a leadership position in the manufacture of high value plant-based phytochemicals (API’s)

What We Do

We are pioneers of green technology and strongly integrate sustainability initiatives into each aspect of our operations.

Use of Green CO₂ and Ethanol for Manufacturing: We use in-house suagrcane based ‘green’ CO₂ and ethanol as clean extraction solvents for manufacturing high value nutraceutical ingredients and recycle all our solvents to make sure our products and processes are entirely sustainable
Zero Solid and Liquid Discharge System: We recycle and reuse all our water and treat 100% of our effluent water discharged from all our manufacturing activities
Energy from Waste Biomass: We convert all our plant residue post extraction into biomass briquettes and use it as fuel for our boiler. We proudly generate over 70% of our fuel requirement through such initiatives

Getting Started

2008-2013

Manufacturing facility commissioned at Pharmacity, Dehradun with a state-of-the-art SCF CO₂ plant, solvent refining and aqueous extraction facility 
Strategic tie-up for manufacturing of high value Astaxanthin by SCF –CO₂ extraction
Manufacturing initiated for high-value Thiocolchicoside API and other API ingredients 
Formulation plant started for converting nutraceutical extracts to oleoresins, powders and beadlets

Developing Depth, Expertise and Leadership

2014-2019 

Established leadership in Thiocolchicoside API and achieved highest export volumes for Thiocolchicoside globally
Granted US patent for “Single phase Lutein Ester extraction from tagetes species: Marigold flower meal”

Commissioned new plant for production of Nicotine API as a key portfolio expansion

Adding new Dimensions

2020-2023 

Expansion of Nicotine facility to meet the growing demand for Nicotine API  
Launch of first branded nutraceutical ingredient – MAXICUMA® and LIMAN™ technology platform for converting lipophilic extracts into water-soluble powders 
Launch of SCEMOD™ technology and other branded nutraceutical ingredients range
Successful passing of the EU-GMP sitewide audit by the edqm audit and CEP certification for Thiocolchicoside and Colchicine API’s